Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.

Piazzese C, Foley K, Whybra P, Hurt C, Crosby T, Spezi E.

PLoS One. 2019 Nov 22;14(11):e0225550. doi: 10.1371/journal.pone.0225550. eCollection 2019.

2.

Mitigating the Risk of Infectious Diseases Among Rural Drug Users in Western North Carolina: Results of the Southern Appalachia Test, Link, Care (SA-TLC) Health Care Provider Survey.

Hurt CB, Carpenter DM, Evon DM, Hennessy CM, Rhea SK, Zule WA.

J Rural Health. 2019 Nov 19. doi: 10.1111/jrh.12409. [Epub ahead of print]

PMID:
31742771
3.

The timing of locomotor propulsion in healthy adults walking at multiple speeds.

Kuhman D, Hurt CP.

Hum Mov Sci. 2019 Dec;68:102524. doi: 10.1016/j.humov.2019.102524. Epub 2019 Nov 13.

PMID:
31733429
4.

Association of Infection with Chronic Hepatitis C Virus and Myocardial Infarction in People Living with HIV in the United States.

Williams-Nguyen J, Hawes SE, Nance RM, Lindström S, Heckbert SR, Kim HN, Mathews WC, Cachay ER, Budoff M, Hurt CB, Hunt PW, Geng E, Moore RD, Mugavero MJ, Peter I, Kitahata MM, Saag MS, Crane HM, Delaney JA.

Am J Epidemiol. 2019 Nov 12. pii: kwz236. doi: 10.1093/aje/kwz236. [Epub ahead of print]

PMID:
31712804
5.

Outcome of Weekly Carboplatin-Paclitaxel-based Definitive Chemoradiation in Oesophageal Cancer in Patients Not Considered to be Suitable for Platinum-Fluoropyrimidine-based Treatment: A Multicentre, Retrospective Review.

Owens R, Cox C, Gomberg S, Pan S, Radhakrishna G, Parikh S, Goody R, Hingorani M, Prince S, Bird T, Dorey N, Macgregor U, Al-Chamali H, Hurt C, Mukherjee S.

Clin Oncol (R Coll Radiol). 2019 Oct 26. pii: S0936-6555(19)30439-X. doi: 10.1016/j.clon.2019.09.058. [Epub ahead of print]

PMID:
31662220
6.

Deintensification of Adjuvant Treatment After Transoral Surgery in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer: The Conception of the PATHOS Study and Its Development.

Hargreaves S, Beasley M, Hurt C, Jones TM, Evans M.

Front Oncol. 2019 Oct 1;9:936. doi: 10.3389/fonc.2019.00936. eCollection 2019. Review.

7.

Lower extremity joints and muscle groups in the human locomotor system alter mechanical functions to meet task demand.

Kuhman DJ, Hurt CP.

J Exp Biol. 2019 Oct 21;222(Pt 20). pii: jeb206383. doi: 10.1242/jeb.206383.

PMID:
31558593
8.

Internalized HIV Stigma Is Associated With Concurrent Viremia and Poor Retention in a Cohort of US Patients in HIV Care.

Christopoulos KA, Neilands TB, Hartogensis W, Geng EH, Sauceda J, Mugavero MJ, Crane HM, Fredericksen RJ, Moore RD, Mathews WC, Mayer KH, Chander G, Hurt CB, Johnson MO.

J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):116-123. doi: 10.1097/QAI.0000000000002117.

PMID:
31513551
9.

Assessing a novel way to measure three common rehabilitation outcome measures using a custom mobile phone application.

Lein DH Jr, Willig JH, Smith CR, Curtis JR, Westfall AO, Hurt CP.

Gait Posture. 2019 Sep;73:246-250. doi: 10.1016/j.gaitpost.2019.07.251. Epub 2019 Jul 26.

PMID:
31377580
10.

Dynamic stability during increased walking speeds is related to balance confidence of older adults: a pilot study.

Kongsuk J, Brown DA, Hurt CP.

Gait Posture. 2019 Sep;73:86-92. doi: 10.1016/j.gaitpost.2019.06.018. Epub 2019 Jul 4.

PMID:
31302337
11.

An Electronic Pre-Exposure Prophylaxis Initiation and Maintenance Home Care System for Nonurban Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.

Siegler AJ, Brock JB, Hurt CB, Ahlschlager L, Dominguez K, Kelley CF, Jenness SM, Wilde G, Jameson SB, Bailey-Herring G, Mena LA.

JMIR Res Protoc. 2019 Jun 10;8(6):e13982. doi: 10.2196/13982.

12.

Effects of a Transitional Care Practice for a Vulnerable Population: a Pragmatic, Randomized Comparative Effectiveness Trial.

Liss DT, Ackermann RT, Cooper A, Finch EA, Hurt C, Lancki N, Rogers A, Sheth A, Teter C, Schaeffer C.

J Gen Intern Med. 2019 Sep;34(9):1758-1765. doi: 10.1007/s11606-019-05078-4. Epub 2019 May 29.

PMID:
31144279
13.

Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

Parkinsonism Relat Disord. 2019 Jul;64:220-225. doi: 10.1016/j.parkreldis.2019.04.014. Epub 2019 Apr 20.

PMID:
31036430
14.

Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study.

Kim HN, Nance RM, Williams-Nguyen JS, Chris Delaney JA, Crane HM, Cachay ER, Martin J, Mathews WC, Chander G, Franco R, Hurt CB, Geng EH, Rodriguez B, Moore RD, Saag MS, Kitahata MM; Centers for AIDS Research Network of Integrated Clinical Systems.

Open Forum Infect Dis. 2019 Mar 23;6(4):ofz100. doi: 10.1093/ofid/ofz100. eCollection 2019 Apr.

15.

Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial.

Hurt C, Ramaraj R, Farr A, Morgan M, Williams N, Philips CJ, Williams GT, Gardner G, Porter C, Sampson J, Hillier S, Heard H, Dolwani S; CONSCOP Clinical Research Consortium.

Lancet Gastroenterol Hepatol. 2019 May;4(5):364-375. doi: 10.1016/S2468-1253(19)30035-4. Epub 2019 Mar 16.

PMID:
30885505
16.

Brain-wide cellular resolution imaging of Cre transgenic zebrafish lines for functional circuit-mapping.

Tabor KM, Marquart GD, Hurt C, Smith TS, Geoca AK, Bhandiwad AA, Subedi A, Sinclair JL, Rose HM, Polys NF, Burgess HA.

Elife. 2019 Feb 8;8. pii: e42687. doi: 10.7554/eLife.42687.

17.

Recommendation for the minimum number of steps to analyze when performing the uncontrolled manifold analysis on walking data.

Rosenblatt NJ, Hurt CP.

J Biomech. 2019 Mar 6;85:218-223. doi: 10.1016/j.jbiomech.2019.01.018. Epub 2019 Jan 19.

PMID:
30718066
18.

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2).

Strauss VY, Shaw R, Virdee PS, Hurt CN, Ward E, Tranter B, Patel N, Bridgewater J, Parsons P, Radhakrishna G, O'Neill E, Sebag-Montefiore D, Hawkins M, Corrie PG, Maughan T, Mukherjee S.

BMC Cancer. 2019 Feb 4;19(1):121. doi: 10.1186/s12885-019-5307-z.

19.

Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.

Hightow-Weidman LB, Magnus M, Beauchamp G, Hurt CB, Shoptaw S, Emel L, Piwowar-Manning E, Mayer KH, Nelson LE, Wilton L, Watkins P, Whitfield D, Fields SD, Wheeler D.

Clin Infect Dis. 2019 Oct 15;69(9):1597-1604. doi: 10.1093/cid/ciy1141.

PMID:
30615169
20.

The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency Virus.

Breskin A, Westreich D, Hurt CB, Cole SR, Hudgens MG, Seaberg EC, Thio CL, Tien PC, Adimora AA.

Clin Infect Dis. 2019 Oct 15;69(9):1613-1620. doi: 10.1093/cid/ciz008.

PMID:
30615096
21.

Canary in the Coal Mine? Transmitted Mutations Conferring Resistance to All Integrase Strand Transfer Inhibitors in a Treatment-Naive Patient.

McGee KS, Okeke NL, Hurt CB, McKellar MS.

Open Forum Infect Dis. 2018 Nov 8;5(11):ofy294. doi: 10.1093/ofid/ofy294. eCollection 2018 Nov.

22.

Assessing a novel way to measure step count while walking using a custom mobile phone application.

Hurt CP, Lein DH Jr, Smith CR, Curtis JR, Westfall AO, Cortis J, Rice C, Willig JH.

PLoS One. 2018 Nov 6;13(11):e0206828. doi: 10.1371/journal.pone.0206828. eCollection 2018.

23.

Changing behaviour 'more or less'-do theories of behaviour inform strategies for implementation and de-implementation? A critical interpretive synthesis.

Patey AM, Hurt CS, Grimshaw JM, Francis JJ.

Implement Sci. 2018 Oct 29;13(1):134. doi: 10.1186/s13012-018-0826-6. Review.

24.

The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus.

Breskin A, Westreich D, Cole SR, Hudgens MG, Hurt CB, Seaberg EC, Thio CL, Tien PC, Adimora AA.

Clin Infect Dis. 2019 Mar 19;68(7):1152-1159. doi: 10.1093/cid/ciy588. Erratum in: Clin Infect Dis. 2019 Mar 11;:.

25.

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.

Gollins S, West N, Sebag-Montefiore D, Susnerwala S, Falk S, Brown N, Saunders M, Quirke P, Ray R, Parsons P, Griffiths G, Maughan T, Adams R, Hurt C.

Br J Cancer. 2018 Sep;119(6):697-706. doi: 10.1038/s41416-018-0209-4. Epub 2018 Aug 17.

26.

Altered joint kinetic strategies of healthy older adults and individuals with Parkinson's disease to walk at faster speeds.

Kuhman D, Hammond KG, Hurt CP.

J Biomech. 2018 Oct 5;79:112-118. doi: 10.1016/j.jbiomech.2018.07.038. Epub 2018 Aug 4.

PMID:
30097267
27.

Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study.

Prout HC, Barham A, Bongard E, Tudor-Edwards R, Griffiths G, Hamilton W, Harrop E, Hood K, Hurt CN, Nelson R, Porter C, Roberts K, Rogers T, Thomas-Jones E, Tod A, Yeo ST, Neal RD, Nelson A.

Trials. 2018 Aug 4;19(1):419. doi: 10.1186/s13063-018-2803-4.

28.

PrEParing Providers: The Next Challenge in Implementing Human Immunodeficiency Virus Preexposure Prophylaxis.

Hurt CB.

Sex Transm Dis. 2018 Jul;45(7):459-461. doi: 10.1097/OLQ.0000000000000835. No abstract available.

29.

Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.

Manchuelle A, Pontana F, De Groote P, Lebert P, Fertin M, Baijot M, Hurt C, Lamblin N, Debry N, Schurtz G, Pentiah AD, Sudre A, Remy-Jardin M, Lancellotti P, Van Belle E, Bauters C, Lemesle G, Delhaye C.

Arch Cardiovasc Dis. 2018 Nov;111(11):686-701. doi: 10.1016/j.acvd.2018.04.004. Epub 2018 Jun 1.

30.

Effect of forward-directed aiding force on gait mechanics in healthy young adults while walking faster.

Dionisio VC, Hurt CP, Brown DA.

Gait Posture. 2018 Jul;64:12-17. doi: 10.1016/j.gaitpost.2018.05.018. Epub 2018 May 18.

PMID:
29803081
31.

Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.

Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC.

Curr HIV/AIDS Rep. 2018 Jun;15(3):245-254. doi: 10.1007/s11904-018-0393-0. Review.

32.

Repeat Human Immunodeficiency Virus Testing by Transmission Risk Group and Rurality of Residence in North Carolina.

Billock RM, Samoff E, Cope AB, Sampson LA, Hurt CB, Powers KA.

Sex Transm Dis. 2018 Oct;45(10):684-689. doi: 10.1097/OLQ.0000000000000866.

33.

Minimizing Postural Demands of Walking While Still Emphasizing Locomotor Force Generation for Nonimpaired Individuals.

Graham SA, Hurt CP, Brown DA.

IEEE Trans Neural Syst Rehabil Eng. 2018 May;26(5):1003-1010. doi: 10.1109/TNSRE.2018.2810701.

PMID:
29752235
34.

Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.

Thaden JT, Gandhi M, Okochi H, Hurt CB, McKellar MS.

AIDS. 2018 Jun 1;32(9):F1-F4. doi: 10.1097/QAD.0000000000001825.

35.

Stomach Dose-Volume Predicts Acute Gastrointestinal Toxicity in Chemoradiotherapy for Locally Advanced Pancreatic Cancer.

Holyoake DLP, Warren DR, Hurt C, Aznar M, Partridge M, Mukherjee S, Hawkins MA.

Clin Oncol (R Coll Radiol). 2018 Jul;30(7):418-426. doi: 10.1016/j.clon.2018.02.067. Epub 2018 Mar 28.

PMID:
29602584
36.

Which species, how many, and from where: Integrating habitat suitability, population genomics, and abundance estimates into species reintroduction planning.

Malone EW, Perkin JS, Leckie BM, Kulp MA, Hurt CR, Walker DM.

Glob Chang Biol. 2018 Aug;24(8):3729-3748. doi: 10.1111/gcb.14126. Epub 2018 Apr 17.

PMID:
29543361
37.

Integrated Hepatitis C Testing and Linkage to Care at a Local Health Department Sexually Transmitted Disease Clinic: Determining Essential Resources and Evaluating Outcomes.

Rhea S, Seña AC, Hilton A, Hurt CB, Wohl D, Fleischauer A.

Sex Transm Dis. 2018 Apr;45(4):229-232. doi: 10.1097/OLQ.0000000000000748.

PMID:
29465696
38.

Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.

Alderdice M, Richman SD, Gollins S, Stewart JP, Hurt C, Adams R, McCorry AM, Roddy AC, Vimalachandran D, Isella C, Medico E, Maughan T, McArt DG, Lawler M, Dunne PD.

J Pathol. 2018 May;245(1):19-28. doi: 10.1002/path.5051. Epub 2018 Mar 25.

39.

Step-by-step variability of swing phase trajectory area during steady state walking at a range of speeds.

Rumble DD, Hurt CP, Brown DA.

PLoS One. 2018 Jan 25;13(1):e0191247. doi: 10.1371/journal.pone.0191247. eCollection 2018.

40.

Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).

Hurt CN, Jones S, Madden TA, Fiander A, Nordin AJ, Naik R, Powell N, Carucci M, Tristram A.

BJOG. 2018 Aug;125(9):1171-1177. doi: 10.1111/1471-0528.15124. Epub 2018 Feb 9.

41.

Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy.

Willis SJ, Cole SR, Westreich D, Edmonds A, Hurt CB, Albrecht S, Anastos K, Augenbraun M, Fischl M, French AL, Kalapila AG, Karim R, Peters MG, Plankey M, Seaberg EC, Tien PC, Adimora AA.

AIDS. 2018 Mar 13;32(5):653-661. doi: 10.1097/QAD.0000000000001745.

42.

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.

Warren S, Hurt CN, Crosby T, Partridge M, Hawkins MA.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):729-737. doi: 10.1016/j.ijrobp.2017.07.025. Epub 2017 Jul 29.

43.

Comparison of Resistance-Based Walking Cardiorespiratory Test to The Bruce Protocol.

Hurt CP, Bamman M, Naidu A, Brown DA.

J Strength Cond Res. 2017 Dec 11. doi: 10.1519/JSC.0000000000002263. [Epub ahead of print]

44.

A pragmatic randomized comparative effectiveness trial of transitional care for a socioeconomically diverse population: Design, rationale and baseline characteristics.

Schaeffer C, Teter C, Finch EA, Hurt C, Keeter MK, Liss DT, Rogers A, Sheth A, Ackermann R.

Contemp Clin Trials. 2018 Feb;65:53-60. doi: 10.1016/j.cct.2017.12.003. Epub 2017 Dec 9.

PMID:
29233720
45.

Selecting an HIV Test: A Narrative Review for Clinicians and Researchers.

Hurt CB, Nelson JAE, Hightow-Weidman LB, Miller WC.

Sex Transm Dis. 2017 Dec;44(12):739-746. doi: 10.1097/OLQ.0000000000000719. Review.

46.

HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers.

Zhang HL, Rhea SK, Hurt CB, Mobley VL, Swygard H, Seña AC, McKellar MS.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):72-77. doi: 10.1097/QAI.0000000000001546.

47.

The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.

Cox S, Hurt C, Grenader T, Mukherjee S, Bridgewater J, Crosby T.

Radiother Oncol. 2017 Oct;125(1):154-159. doi: 10.1016/j.radonc.2017.08.023. Epub 2017 Sep 8.

48.

Identifying barriers to help-seeking for non-motor symptoms in people with Parkinson's disease.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

J Health Psychol. 2019 Apr;24(5):561-571. doi: 10.1177/1359105316683239. Epub 2016 Dec 1.

PMID:
28810364
49.

Using hospital use trends to improve transitional care.

Feinglass J, Mallama CA, Rogers A, Teter C, Hurt C, Schaeffer C.

Healthc (Amst). 2018 Dec;6(4):259-264. doi: 10.1016/j.hjdsi.2017.08.001. Epub 2017 Aug 8.

PMID:
28800938
50.

Response to: Neoadjuvant chemoradiotherapy for oesophageal cancer: Still looking for a challenger to the CROSS regimen.

Mukherjee S, Hurt CN, Crosby T.

Eur J Cancer. 2017 Sep;83:333-334. doi: 10.1016/j.ejca.2017.06.040. Epub 2017 Jul 24. No abstract available.

PMID:
28751071

Supplemental Content

Support Center